A genetic variant of hypoxia-inducible factor-1α is associated with adverse outcomes in acute kidney injury

Kidney International

Volumn 75, Issue 12, 2009, Pages 1322-1329

  Kolyada, Alexey Y ^a   Tighiouart, Hocine ^b   Perianayagam, Mary C ^a   Liangos, Orfeas ^a   Madias, Nicolaos E ^a   Jaber, Bertrand L ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Angiopoietin 2; Gene polymorphism; HIF 1 ; VEGF A

Indexed keywords

ANGIOPOIETIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN A;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DIALYSIS; DNA POLYMORPHISM; EXON; FEMALE; GENETIC VARIABILITY; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 67349216805     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.68     Document Type: Article

References (44)

1. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370.
2. Liangos O, Wald R, O'Bell J et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006; 1: 43-51.
3. Haase VH. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006; 291: F271-F281.
4. Jaber B, Rao M, Guo D et al. Cytokine promoter gene polymorphisms and mortality in acute renal failure. Cytokine 2004; 25: 212-219.
5. Perianayagam MC, Liangos O, Kolyada AY et al. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18: 255-263.
6. Tanimoto K, Yoshiga K, Eguchi H et al. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 2003; 24: 1779-1783.
7. Parikh SM, Mammoto T, Schultz A et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3: e46.
8. Shapiro NI, Yano K, Okada H et al. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 2008; 29: 452-457.
9. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000; 88: 1474-1480.
10. Clifford SC, Astuti D, Hooper L et al. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene 2001; 20: 5067-5074.
11. Fu XS, Choi E, Bubley GJ et al. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 2005; 63: 215-221.
12. Yamada N, Horikawa Y, Oda N et al. Genetic variation in the hypoxia-inducible factor-1alpha gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab 2005; 90: 5841-5847.
13. Ollerenshaw M, Page T, Hammonds J et al. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 2004; 153: 122-126.
14. Lee JY, Choi JY, Lee KM et al. Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women. Clin Chim Acta 2008; 389: 167-170.
15. Koukourakis MI, Papazoglou D, Giatromanolaki A et al. C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer. Lung Cancer 2006; 53: 257-262.
16. Resar JR, Roguin A, Voner J et al. Hypoxia-inducible factor 1alpha polymorphism and coronary collaterals in patients with ischemic heart disease. Chest 2005; 128: 787-791.
17. Matsumoto M, Makino Y, Tanaka T et al. Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003; 14: 1825-1832.
18. Weidemann A, Bernhardt WM, Klanke B et al. HIF activation protects from acute kidney injury. J Am Soc Nephrol 2008; 19: 486-494.
19. Rosenberger C, Heyman SN, Rosen S et al. Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia. Kidney Int 2005; 67: 531-542.
20. Peyssonnaux C, Cejudo-Martin P, Doedens A et al. Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 2007; 178: 7516-7519.
21. Choi HJ, Song BJ, Gong YD et al. Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2. Br J Pharmacol 2008; 154: 114-125.
22. Blouin CC, Page EL, Soucy GM et al. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 2004; 103: 1124-1130.
23. Frede S, Stockmann C, Freitag P et al. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem J 2006; 396: 517-527.
24. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002; 64: 993-998.
25. Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-4613.
26. Senger DR, Galli SJ, Dvorak AM et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-985.
27. Chandra A, Barillas S, Suliman A et al. A novel fluorescence-based cellular permeability assay. J Biochem Biophys Methods 2007; 70: 329-333.
28. Kelly BD, Hackett SF, Hirota K et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003; 93: 1074-1081.
29. Fong GH. Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis 2008; 11: 121-140.
30. Yamakawa M, Liu LX, Date T et al. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 2003; 93: 664-673.
31. Orfanos SE, Kotanidou A, Glynos C et al. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007; 35: 199-206.
32. Ganter MT, Cohen MJ, Brohi K et al. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? Ann Surg 2008; 247: 320-326.
33. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P et al. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008.
34. Hou SH, Bushinsky DA, Wish JB et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983; 74: 243-248.
35. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
36. K/DOQI NKF. Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-S266.
37. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256.
38. Knaus WA, Draper EA, Wagner DP et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
39. Knaus WA, Wagner DP. Multiple systems organ failure: epidemiology and prognosis. Crit Care Clin 1989; 5: 221-232.
40. Ito A, Hirota S, Mizuno H et al. Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathol Int 1995; 45: 715-720.
41. Maloney JP, Silliman CC, Ambruso DR et al. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998; 275(3 Part 2): H1054-H1061.
42. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 2005; 84: 434-439.
43. Stone C, Koo CY. Additive splines in statistics. In: Proceedings of the Statistical Computing Section of the American Statistical Association 1995: 45-48.
44. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2005. (Accessed at http:// www.R-project.org).